Literature DB >> 21380730

Effect of TNF-α and IL-1β genetic variants on the development of myocardial infarction in Turkish population.

Umit Zeybek1, Bahar Toptas, Zeynep Ermis Karaali, Mehmet Kendir, Bedia Cakmakoglu.   

Abstract

Tumor necrosis factor-alpha (TNF-α) and interleukin 1 beta (IL-1β) genetic variants which resulting in TNF-α and IL-1 overproduction may increase susceptibility to autoimmune diseases such as atherosclerosis. We have studied the association of TNF-α G308A and IL-1β (+3953) C/T polymorphism with myocardial infarction in Turkish population. 143 patients with myocardial infarction and 213 age-matched healthy controls were included in the study. In univariant analysis, the frequencies of IL-1β, TNF-α genotype or allele, and haplotype of C:A and T:A were significantly elevated in patients when compared with those of controls. GA genotype of TNF-α, T allele of IL-1β and A of TNF-α allele seem to be risk factors for myocardial infarction. In contrast, CC genotype of IL-1β and GG genotype of TNF-α have protective effect against myocardial infarction. In multivariate logistic regression analysis, TNF-α A allele, gender and smoking were associated with myocardial infarction. In conclusion, we can state that TNF-α A allele might be associated with myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21380730     DOI: 10.1007/s11033-011-0701-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

1.  Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product.

Authors:  A G Wilson; F S di Giovine; A I Blakemore; G W Duff
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

4.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

Authors:  K M Kroeger; K S Carville; L J Abraham
Journal:  Mol Immunol       Date:  1997-04       Impact factor: 4.407

Review 5.  Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease.

Authors:  L J Abraham; K M Kroeger
Journal:  J Leukoc Biol       Date:  1999-10       Impact factor: 4.962

6.  Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease.

Authors:  R A Allen; E M Lee; D H Roberts; B K Park; M Pirmohamed
Journal:  Eur J Clin Invest       Date:  2001-10       Impact factor: 4.686

7.  Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity.

Authors:  S M Herrmann; S Ricard; V Nicaud; C Mallet; D Arveiler; A Evans; J B Ruidavets; G Luc; L Bara; H J Parra; O Poirier; F Cambien
Journal:  Eur J Clin Invest       Date:  1998-01       Impact factor: 4.686

Review 8.  Female gender, myocardial remodeling and cardiac failure: are women protected from increased myocardiocyte apoptosis?

Authors:  Giuseppe G L Biondi-Zoccai; Alfonso Baldi; Luigi M Biasucci; Antonio Abbate
Journal:  Ital Heart J       Date:  2004-07

9.  Tumour necrosis factor alpha in severe congestive cardiac failure.

Authors:  D P Dutka; J S Elborn; F Delamere; D J Shale; G K Morris
Journal:  Br Heart J       Date:  1993-08

10.  A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro.

Authors:  F Pociot; J Mølvig; L Wogensen; H Worsaae; J Nerup
Journal:  Eur J Clin Invest       Date:  1992-06       Impact factor: 4.686

View more
  8 in total

Review 1.  Elevated serum levels of ghrelin and TNF-α in patients with cyanotic and acyanotic congenital heart disease.

Authors:  Sai Zhang; Gong-Liang Guo; Li-Li Yang; Li-Qun Sun
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

2.  Association between the TNF-α G-308A polymorphism and risk of ischemic heart disease: a meta-analysis.

Authors:  Jiarong Wang; Yazhou He; Yang Yang; Tiange Song; Nan Chen; Yanhong Zhou
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Associations between interleukin-1 gene polymorphisms and coronary heart disease risk: a meta-analysis.

Authors:  Liang Zhou; Jianguang Cai; Gang Liu; Yuan Wei; Hui Tang
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 4.  Tumor necrosis factor-alpha gene polymorphisms and susceptibility to ischemic heart disease: A systematic review and meta-analysis.

Authors:  Peng Zhang; Xiaomei Wu; Guangxiao Li; Qiao He; Huixu Dai; Cong Ai; Jingpu Shi
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach.

Authors:  Weizhen Li; Songwen Chen; Genqing Zhou; Hongli Li; Lan Zhong; Shaowen Liu
Journal:  Saudi J Biol Sci       Date:  2016-11-10       Impact factor: 4.219

6.  Combination of magnetic resonance imaging and targeted contrast agent for the diagnosis of myocardial infarction.

Authors:  Jiangjun Qin; Shuchang Zhou; Zhiwei Li; Yinan Chen; Qun Qin; Tao Ai
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

7.  Gene polymorphism associated with TNF-α (G308A) IL-6 (C174G) and susceptibility to coronary atherosclerotic heart disease: A meta-analysis.

Authors:  Jiang Yuepeng; Xiaoxuan Zhao; Yang Zhao; Liu Li
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

Review 8.  Association between IL-1β + 3954C/T polymorphism and myocardial infarction risk: A meta-analysis.

Authors:  Yizhen Fang; Huabin Xie; Zhiyuan Lin
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.